Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.

Publication Type:

Journal Article

Source:

Menopause (New York, N.Y.), Volume 20, Issue 3, p.261-8 (2013)

Keywords:

2013, Clinical Research Division, March 2013, Public Health Sciences Division

Abstract:

Vasomotor symptoms (VMS) recur after discontinuation of hormonal therapy. Selective serotonin reuptake inhibitors (SSRIs) are used increasingly to treat VMS, but whether VMS recur after cessation of SSRI is unknown. We hypothesized that relapse of VMS to baseline levels after SSRI cessation would be common and predicted by menopausal and psychological characteristics.